5 results
PRE 14A
ALGS
Aligos Therapeutics, Inc.
16 Apr 24
Preliminary proxy
5:27pm
is evidenced in part by its decision to designate Mr. Nielsen as our lead independent director. In addition, in connection with his nomination for election … , our Nominating and Corporate Governance Committee evaluated Mr. Nielsen’s performance as our lead independent director and as a member of certain
DEF 14A
ALGS
Aligos Therapeutics, Inc.
27 Apr 21
Definitive proxy
4:15pm
Officer, has been appointed the Chair of the Board and Mr. Nielsen will serve as the lead independent director of our Board. In Mr. Nielsen’s role … as lead independent director he will preside over the executive sessions of the Board and serve as a liaison between management and the Board.
Our Board
- Prev
- 1
- Next